Claus Becker

745 total citations
17 papers, 552 citations indexed

About

Claus Becker is a scholar working on Pharmaceutical Science, Inorganic Chemistry and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Claus Becker has authored 17 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmaceutical Science, 4 papers in Inorganic Chemistry and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Claus Becker's work include Fluorine in Organic Chemistry (5 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Gastrointestinal Tumor Research and Treatment (3 papers). Claus Becker is often cited by papers focused on Fluorine in Organic Chemistry (5 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Gastrointestinal Tumor Research and Treatment (3 papers). Claus Becker collaborates with scholars based in United States, Switzerland and Germany. Claus Becker's co-authors include Antonio Mezzetti, Gunhild Hølmer, Antonio Togni, Martin Althaus, Iris Kieltsch, D. Broggini, Cristina Bonaccorsi, Lauren J. Rogak, Amylou C. Dueck and Mary Lou Smith and has published in prestigious journals such as Journal of Clinical Oncology, Inorganic Chemistry and European Journal of Cancer.

In The Last Decade

Claus Becker

17 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Claus Becker United States	9	212	135	116	94	94	17	552
Brad D. Maxwell United States	11	894 4.2×	328 2.4×	61 0.5×	190 2.0×	212 2.3×	34	1.6k
Karen A. Rossi United States	19	515 2.4×	37 0.3×	100 0.9×	363 3.9×	28 0.3×	45	1.3k
Uwe J. Ries Germany	11	362 1.7×	24 0.2×	71 0.6×	290 3.1×	27 0.3×	17	1.2k
Christopher M. Waldmann United States	11	123 0.6×	72 0.5×	90 0.8×	162 1.7×	29 0.3×	19	796
Hirotaka Kashiwagi Japan	10	189 0.9×	134 1.0×	76 0.7×	44 0.5×	53 0.6×	21	450
Kim Frisch Denmark	16	281 1.3×	9 0.1×	165 1.4×	66 0.7×	69 0.7×	32	692
Michael J. Orwat United States	13	288 1.4×	48 0.4×	45 0.4×	181 1.9×	19 0.2×	16	782
Mehmet Akif Sari France	11	115 0.5×	40 0.3×	403 3.5×	352 3.7×	30 0.3×	12	1.1k
Nicholas Stock United States	14	187 0.9×	14 0.1×	77 0.7×	206 2.2×	22 0.2×	28	611
Thomas Antonsson Sweden	12	257 1.2×	20 0.1×	68 0.6×	176 1.9×	63 0.7×	25	842

Countries citing papers authored by Claus Becker

Since Specialization

Citations

This map shows the geographic impact of Claus Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claus Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claus Becker more than expected).

Fields of papers citing papers by Claus Becker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claus Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claus Becker. The network helps show where Claus Becker may publish in the future.

Co-authorship network of co-authors of Claus Becker

This figure shows the co-authorship network connecting the top 25 collaborators of Claus Becker. A scholar is included among the top collaborators of Claus Becker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claus Becker. Claus Becker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Schöffski, Patrick, Suzanne George, Michael C. Heinrich, et al.. (2022). Patient-reported outcomes in individuals with advanced gastrointestinal stromal tumor treated with ripretinib in the fourth-line setting: analysis from the phase 3 INVICTUS trial. BMC Cancer. 22(1). 1302–1302. 4 indexed citations

Baumann, Florian, et al.. (2022). Imaging, post-processing and navigation: Surgical applications in pelvic fracture treatment. Injury. 53. S16–S22. 7 indexed citations

Gelderblom, Hans, Robin L. Jones, Jean‐Yves Blay, et al.. (2022). Patient reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after imatinib treatment in INTRIGUE: A phase 3 open-label study.. Journal of Clinical Oncology. 40(16_suppl). 11541–11541. 2 indexed citations

Grenacher, Lars, Markus Juchems, Thomas C. Lauenstein, et al.. (2021). Impact of the COVID 19 Pandemic on Radiological Imaging in Germany. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 194(6). 625–633. 2 indexed citations

Dueck, Amylou C., Claus Becker, Lauren J. Rogak, et al.. (2020). Composite grading algorithm for National Cancer Institute’s PRO-CTCAE.. Journal of Clinical Oncology. 38(15_suppl). 7018–7018. 3 indexed citations

Basch, Ethan, Claus Becker, Lauren J. Rogak, et al.. (2020). Composite grading algorithm for the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Clinical Trials. 18(1). 104–114. 144 indexed citations

Heinrich, Michael C., Suzanne George, John Zalcberg, et al.. (2020). Quality of life (QoL) and self-reported function with ripretinib in ≥4th-line therapy for patients with gastrointestinal stromal tumors (GIST): Analyses from INVICTUS.. Journal of Clinical Oncology. 38(15_suppl). 11535–11535. 10 indexed citations

Hubner, Richard, Antonio Cubillo, Jean‐Frédéric Blanc, et al.. (2018). Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorin. European Journal of Cancer. 106. 24–33. 36 indexed citations

Kaiser, Lee D., et al.. (2012). Decision Making for a Companion Diagnostic in an Oncology Clinical Development Program. Drug Information Journal. 46(3). 294–302. 2 indexed citations

10.

Kaiser, Lee D., et al.. (2011). Decision Making for a Companion Diagnostic in an Oncology Clinical Development Program. Drug Information Journal. 45(5). 645–655. 4 indexed citations

11.

Althaus, Martin, Claus Becker, Antonio Togni, & Antonio Mezzetti. (2007). Ruthenium-Catalyzed Asymmetric Electrophilic Fluorination of 1,3-Dicarbonyl Compounds. Organometallics. 26(24). 5902–5911. 55 indexed citations

12.

Bonaccorsi, Cristina, Martin Althaus, Claus Becker, Antonio Togni, & Antonio Mezzetti. (2006). Chiral Ru/PNNP complexes in catalytic and stoichiometric electrophilic O- and F-atom transfer to 1,3-dicarbonyl compounds. Pure and Applied Chemistry. 78(2). 391–396. 43 indexed citations

13.

Becker, Claus, Iris Kieltsch, D. Broggini, & Antonio Mezzetti. (2003). Bridging Fluorides and Hard/Soft Mismatch in d⁶and d⁸Complexes: The Case of [Tl(μ-F)₃Ru(PPh₃)₃]. Inorganic Chemistry. 42(25). 8417–8429. 37 indexed citations

14.

Mezzetti, Antonio & Claus Becker. (2002). . Helvetica Chimica Acta. 85(9). 2686–2703. 59 indexed citations

15.

Togni, Antonio, Antonio Mezzetti, Claus Becker, et al.. (2001). Developing Catalytic Enantioselective Fluorination. CHIMIA International Journal for Chemistry. 55(10). 801–801. 36 indexed citations

16.

Becker, Claus, et al.. (1994). A more accurate gas chromatographic method for the analysis of butter oil fatty acids by estimation of relative response factors. Chemometrics and Intelligent Laboratory Systems. 23(1). 231–234. 3 indexed citations

17.

Becker, Claus, et al.. (1993). Regiospecific analysis of triacylglycerols using allyl magnesium bromide. Lipids. 28(2). 147–149. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact